ep 459 has been researched along with leucine in 7 studies
| Studies (ep 459) | Trials (ep 459) | Recent Studies (post-2010) (ep 459) | Studies (leucine) | Trials (leucine) | Recent Studies (post-2010) (leucine) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 28,515 | 744 | 4,178 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishida, E; Ito, M; Sato, A; Shigeta, S; Takami, Y; Tanabe, F | 1 |
| Aihara, H; Hanada, K; Isogai, K; Shibata, N; Tsuchida, K | 1 |
| Chappell, CL; Dresden, MH; Zerda, KS | 1 |
| Amaya, N; Miyatake, T; Sato, S; Yanagisawa, K | 1 |
| Grinde, B | 1 |
| Barrett, AJ; Brown, MA; Hanada, K; Kembhavi, AA; Kirschke, H; Knight, CG; Tamai, M | 1 |
| Ikemoto, M; Kano, M; Katunuma, N; Kishi, K; Kitano, T; Nikawa, T; Shizuka, F; Towatari, T; Watanabe, C; Yoshimoto, M | 1 |
7 other study(ies) available for ep 459 and leucine
| Article | Year |
|---|---|
The thiol proteinase inhibitors improve the abnormal rapid down-regulation of protein kinase C and the impaired natural killer cell activity in (Chediak-Higashi syndrome) beige mouse.
Topics: Animals; Calpain; Chediak-Higashi Syndrome; Cysteine Proteinase Inhibitors; Cytotoxicity, Immunologic; Disease Models, Animal; Killer Cells, Natural; Killer Factors, Yeast; Leucine; Leupeptins; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Protein Biosynthesis; Protein Kinase C; Proteins; Tetradecanoylphorbol Acetate | 1989 |
Degradation of myocardial structural proteins in myocardial infarcted dogs is reduced by Ep459, a cysteine proteinase inhibitor.
Topics: Animals; Calpain; Cathepsin B; Cathepsin L; Cathepsins; Coronary Disease; Cysteine Endopeptidases; Dogs; Electrophoresis, Polyacrylamide Gel; Endopeptidases; Female; Kinetics; Leucine; Male; Muscle Proteins; Myocardial Infarction; Myocardium; Protease Inhibitors | 1986 |
Schistosoma mansoni: expression and role of cysteine proteinases in developing schistosomula.
Topics: Animals; Cysteine Endopeptidases; Fluorescent Antibody Technique; Hemin; Immunoblotting; Larva; Leucine; Protease Inhibitors; Schistosoma mansoni | 1988 |
Degradation of myelin basic protein by calcium-activated neutral protease (CANP) in human brain and inhibition by E-64 analogue.
Topics: Brain; Calpain; Endopeptidases; Humans; Kinetics; Leucine; Myelin Basic Protein; Protease Inhibitors | 1983 |
Selective inhibition of lysosomal protein degradation by the thiol proteinase inhibitors E-64, Ep-459 and Ep-457 in isolated rat hepatocytes.
Topics: Animals; Cysteine Endopeptidases; Drug Interactions; Kinetics; Leucine; Leupeptins; Liver; Lysosomes; Male; Propylamines; Protease Inhibitors; Rats; Rats, Inbred Strains | 1982 |
L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.
Topics: Binding Sites; Cathepsin B; Cathepsin H; Cathepsin L; Cathepsins; Cysteine Endopeptidases; Endopeptidases; Kinetics; Leucine; Models, Biological; Protease Inhibitors; Structure-Activity Relationship | 1982 |
A cysteine protease inhibitor prevents suspension-induced declines in bone weight and strength in rats.
Topics: Animals; Bone and Bones; Bone Resorption; Calcium; Cathepsin K; Cathepsins; Collagenases; Cysteine Proteinase Inhibitors; Etidronic Acid; Femur; Hydroxyproline; Leucine; Male; Organ Size; Rats; Rats, Wistar; Weightlessness | 2002 |